Evidence map›Paper›PMID 39404040›Full record

ArticleCurrent protocols2024

Genetic Modification of Mice Using Prime Editing.

Amr R Salem, Xiaoling Xie, Susan H Griffin, Lin Gan, Joseph M Miano

Abstract read
In one paragraph

Article in Current protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amr R SalemVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.ORCID http://orcid.org/0000-0001-8269-1420
Xiaoling XieDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia.
Susan H GriffinVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Lin GanDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia.
Joseph M MianoVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.

Funding

Function and Regulation of MEIS1 in Vascular DiseaseK99HL169827 · NHLBI · AUGUSTA UNIVERSITY · PI SALEM, AMR · 2023 to 2024
$227k
NHLBI NIH HHS K99 HL169827NIH HHS HL169827
6 · The paper itself

Abstract

Genetically modifying mice traditionally involved complex methods of designing and validating targeting constructs, embryonic stem cell electroporation and selection, blastocyst injection, and breeding chimeras for germline transmission. Such arduous steps were best carried out by specialized gene targeting cores in academia or through expensive commercial vendors. Further, the time from initiation to completion of a project often took at least 1 year and, in some cases, much longer (or never), with no guarantees of success. The RNA-programmable CRISPR system of gene editing has greatly streamlined the generation of gene modifications (e.g., small substitutions, insertions, and deletions) in the mouse with high rates of success. Several editing platforms exist for gene/genome targeting in mice and other animal models previously difficult or impossible to alter. Here, we provide a simplified method of generating genetically modified mice using the prime editing platform. © 2024 Wiley Periodicals LLC. Basic Protocol 1: Design, cloning, and synthesis of engineered pegRNA (epegRNA) Basic Protocol 2: Microinjection of PE2 components into mouse zygote Basic Protocol 3: Genotyping founder mice and breeding for germline transmission.

Indexed as

CRISPR-Cas SystemsGene EditingAnimalsFemaleMaleMiceMicroinjectionsCRISPRgene editingguide RNAmicroinjectionmouseprime editing

Identifiers

PMID39404040
PMCPMC12993870

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.